Bringing Hope
to People Living with Neurodegenerative Diseases

Investor Presentation

Latest News Release

Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Treatments

Alzheimers: ALPHA-1062

A New Approach

Quick Links

About ACI
ALPHA-0602
Team
Contact

Latest News

View All

Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease

View All

TSX-V: ACOG

15 min delay

Last$0.44

Change$-0.04

Open0.45

Vol28,252

High0.45

Low0.43

Stock Information